참고문헌
- Tanaka H, Shigenobu K. Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels. Cardiovasc Drug Rev 2002;20:81-92.
- Hagiwara N, Irisawa H, Kameyama M. Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol 1988;395:233-53. https://doi.org/10.1113/jphysiol.1988.sp016916
- Masumiya H, Shijuku T, Tanaka H, Shigenobu K. Inhibition of myocardial L- and T-type Ca2+ currents by efonidipine: possible mechanism for its chronotropic effect. Eur J Pharmacol 1998;349:351-7. https://doi.org/10.1016/S0014-2999(98)00204-0
- Tanaka T, Tsutamoto T, Sakai H, Fujii M, Yamamoto T, Horie M. Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension. Hypertens Res 2007;30:691-7. https://doi.org/10.1291/hypres.30.691
- Shimizu M, Ogawa K, Sasaki H, et al. Effects of efonidipine, an L- and T-Type dual calcium channel blocker, on heart rate and blood pressure in patients with mild to severe hypertension: an uncontrolled, openlabel pilot study. Current Ther Res 2003;64:707-14. https://doi.org/10.1016/j.curtheres.2003.11.004
- Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005;26:967-74. https://doi.org/10.1093/eurheartj/ehi190
- Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, Ducimetiere P. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 2005;352:1951-8. https://doi.org/10.1056/NEJMoa043012
- Palatini P, Benetos A, Grassi G, et al. Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. J Hypertens 2006;24:603-10. https://doi.org/10.1097/01.hjh.0000217838.49842.1e
- Gillman MW, Kannel WB, Belanger A, D'Agostino RB. Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J 1993;125:1148-54. https://doi.org/10.1016/0002-8703(93)90128-V
- Chung JW, Lee HY, Kim CH, et al. Losartan/hydrochlorothiazide fixed combination versus amlodipine monotherapy in Korean patients with mild to moderate hypertension. Korean Circ J 2009;39:151-6. https://doi.org/10.4070/kcj.2009.39.4.151
- Fox K, Borer JS, Camm AJ, et al. Resting heart rate in cardiovascular disease. J Am Coll Cardiol 2007;50:823-30. https://doi.org/10.1016/j.jacc.2007.04.079
- Cha DH, Cha YS, Kook JH, et al. Clinical efficacy of carvedilol in patients with moderate to severe congestive heart failure. Korean Circ J 1998;28:523-31.
- The Israeli Sprint Study Group. Secondary prevention reinfarction Israeli nifedipine trial (SPRINT): a randomized intervention trial of nifedipine in patients with acute myocardial infarction. Eur Heart J 1988;9:354-64.
- Goldbourt U, Behar S, Reicher-Reiss H, Zion M, Mandelzweig L, Kaplinsky E. Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study. Arch Intern Med 1993;153:345-53. https://doi.org/10.1001/archinte.153.3.345
- Furberg CD, Psaty BM, Meyer JV. Nifedipine: Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-31. https://doi.org/10.1161/01.CIR.92.5.1326
- Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995;274:620-5. https://doi.org/10.1001/jama.274.8.620
- Kim DW, Seo JD, Cho SW, et al. Antihypertensive efficacy and safety of perindopril versus nifedipine in high salt intake essential hypertensives: a double-blind parallel group study. Korean Circ J 1994;24:156-63. https://doi.org/10.4070/kcj.1994.24.1.156
- Furukawa T, Nukada T, Miura R, et al. Differential blocking action of dihydropyridine Ca2+ antagonists on a T-type Ca2+ channel (alpha1G) expressed in Xenopus oocytes. J Cardiovasc Pharmacol 2005;45:241-6. https://doi.org/10.1097/01.fjc.0000154374.88283.15
- Furukawa T, Yamakawa T, Midera T, Sagawa T, Mori Y, Nukada T. Selectivities of dihydropyridine derivatives in blocking Ca(2+) channel subtypes expressed in Xenopus oocytes. J Pharmacol Exp Ther 1999;291:464-73.
- Morimoto S, Jo F, Maki K, Iwasaka T. Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress. Clin Exp Hypertens 2009;31:83-91. https://doi.org/10.1080/10641960802627363
- Kinoshita H, Kuwahara K, Takano M, et al. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure. Circulation 2009;120:743-52. https://doi.org/10.1161/CIRCULATIONAHA.109.857011
- Bloch MJ. British hypertension society recommends that beta-blockers are no longer indicated as initial treatment of hypertension: has the pendulum swung too far? J Clin Hypertens 2007;9:99-102. https://doi.org/10.1111/j.1524-6175.2007.06312.x
- Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension: a meta-analysis. Lancet 2005;366:1545-53. https://doi.org/10.1016/S0140-6736(05)67573-3
- Palatini P, Benetos A, Julius S. Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug therapy. Drugs 2006;66:133-44. https://doi.org/10.2165/00003495-200666020-00001
피인용 문헌
- Efficacy and safety of the dual L- and T-type calcium channel blocker, ACT-280778: a proof-of-concept study in patients with mild-to-moderate essential hypertension vol.29, pp.4, 2010, https://doi.org/10.1038/jhh.2014.79
- Disruption of Calcium Signaling in Fibroblasts and Attenuation of Bleomycin-Induced Fibrosis by Nifedipine vol.53, pp.4, 2010, https://doi.org/10.1165/rcmb.2015-0009oc
- Pharmacokinetics, Safety and Tolerability of Tylerdipine Hydrochloride, a Novel Dihydropyridine Dual L/T-type Calcium Channel Blocker, after Single and Multiple Oral Doses in Healthy Chinese Subjects vol.39, pp.1, 2019, https://doi.org/10.1007/s40261-018-0722-5